TREAT Act

1/11/2023, 1:31 PM

Congressional Summary of HR 2536

Recovery Enhancement for Addiction Treatment Act or the TREAT Act

Amends the Controlled Substances Act to increase the number of patients that a qualifying practitioner dispensing narcotic drugs for maintenance or detoxification treatment is initially allowed to treat from 30 to 100 patients per year.

Allows a qualifying physician, after one year, to request approval to treat an unlimited number of patients under specified conditions, including that he or she: (1) agrees to fully participate in the Prescription Drug Monitoring Program of the state in which the practitioner is licensed, (2) practices in a qualified practice setting, and (3) has completed at least 24 hours of training regarding treatment and management of opiate-dependent patients for substance use disorders provided by specified organizations.

Revises the definition of a "qualifying practitioner" to include: (1) a physician who holds a board certification from the American Board of Addiction Medicine; and (2) a nurse practitioner or physicians assistant who is licensed under state law to prescribe schedule III, IV, or V medications for pain, who has specified training or experience that demonstrates specialization in the ability to treat opiate-dependent patients, who practices under the supervision of, or prescribes opioid addiction therapy in collaboration with, a licensed physician who holds an active waiver to prescribe schedule III, IV, or V narcotic medications for opioid addiction therapy, and who practices in a qualified practice setting.

Directs the Comptroller General to initiate an evaluation of the effectiveness of this Act, including an evaluation of: (1) changes in the availability and use of medication-assisted treatment for opioid addiction, (2) the quality of medication-assisted treatment programs, (3) diversion of opioid addiction treatment medication, and (4) changes in state or local policies and legislation relating to opioid addiction treatment.

Current Status of Bill HR 2536

Bill HR 2536 is currently in the status of Bill Introduced since May 21, 2015. Bill HR 2536 was introduced during Congress 114 and was introduced to the House on May 21, 2015.  Bill HR 2536's most recent activity was Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations. as of June 16, 2015

Bipartisan Support of Bill HR 2536

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
27
Democrat Cosponsors
19
Republican Cosponsors
8
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 2536

Primary Policy Focus

Health

Potential Impact Areas

Congressional oversightDrug therapyDrug trafficking and controlled substancesDrug, alcohol, tobacco useGovernment studies and investigationsHealth facilities and institutionsHealth personnelPrescription drugs
Start holding our government accountable!

Comments

Latest Bills

SAVE Act
Bill HR 22April 2, 2025
Providing for consideration of the joint resolution (S.J. Res. 18) disapproving the rule submitted by the Bureau of Consumer Financial Protection relating to "Overdraft Lending: Very Large Financial Institutions''; providing for consideration of the joint resolution (S.J. Res. 28) disapproving the rule submitted by the Bureau of Consumer Financial Protection relating to ''Defining Larger Participants of a Market for General-Use Digital Consumer Payment Applications''; providing for consideration of the bill (H.R. 1526) to amend title 28, United States Code, to limit the authority of district courts to provide injunctive relief, and for other purposes; providing for consideration of the bill (H.R. 22) to amend the National Voter Registration Act of 1993 to require proof of United States citizenship to register an individual to vote in elections for Federal office, and for other purposes; and for other purposes.
Bill HRES 282April 2, 2025
A joint resolution disapproving the rule submitted by the Bureau of Consumer Financial Protection relating to "Overdraft Lending: Very Large Financial Institutions".
Bill SJRES 18April 2, 2025
A joint resolution disapproving the rule submitted by the Bureau of Consumer Financial Protection relating to "Defining Larger Participants of a Market for General-Use Digital Consumer Payment Applications".
Bill SJRES 28April 2, 2025
Providing for the consideration of the resolution (H. Res. 23) permitting parental remote voting by proxy, and for other purposes.
Bill HRES 164April 2, 2025
NORRA of 2025
Bill HR 1526April 2, 2025
Strengthening Support for American Manufacturing Act
Bill S 99April 2, 2025
American Music Tourism Act of 2025
Bill S 195April 2, 2025
ADS for Mental Health Services Act
Bill S 414April 2, 2025
A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes.
Bill S 1040April 2, 2025
Heroin and Prescription Drug Abuse Prevention and Reduction Act
Bill S 2562January 11, 2023
Comprehensive Behavioral Health Reform and Recovery Act of 2016
Bill HR 4435January 11, 2023
Heroin and Prescription Drug Abuse Prevention and Reduction Act
Bill HR 4396January 11, 2023